References
Perimenopause and menopause
2 min read
Verified Checked against the primary source during this build.
From tool Carried over from the reference list of the linked tool, where it was verified at build time.
Re-verify Cited from general knowledge; confirm against PubMed before this page is treated as final.
- Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97(4):1159–1168.Re-verify The STRAW+10 staging framework applied by the Perimenopause Stage Finder. Confirm volume, issue and pagination — this citation also appeared in Menopause and Climacteric in 2012, and the versions differ.
- The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767–794.From tool Candidacy criteria, contraindications, route-of-administration risk differences, progestogen comparison, and the timing-window recommendation.
- Shufelt CL, Brown V, Carpenter JS, et al; NAMS 2023 Nonhormone Therapy Position Statement Advisory Panel. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023;30(6):573–590.From tool Evidence grades and effect sizes for non-hormonal treatment of vasomotor symptoms.
- Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA. 2013;310(13):1353–1368.From tool Extended WHI follow-up with outcomes stratified by age and timing of initiation — the basis for the statement that the original findings were misapplied to younger women.
- Panay N, Fenton A, Hamoda H, et al; IMS Recommendations Writing Group. International Menopause Society recommendations and key messages on women's midlife health and menopause. Climacteric. 2025;28(6):634–656.From tool GRADE-based recommendations applied by the HRT Candidacy & Timing Navigator.
Where a claim on this site could not be traced to one of the sources in these lists, it is not stated. Where two sources disagree, both are shown rather than reconciled. Corrections are welcome — obmd.com.